# Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19

> **NCT05210179** · PHASE2 · COMPLETED · sponsor: **Health Institutes of Turkey** · enrollment: 65 (actual)

## Conditions studied

- COVID-19
- Sars-CoV-2 Infection

## Interventions

- **BIOLOGICAL:** TURKOVAC-Dollvet
- **BIOLOGICAL:** TURKOVAC-Koçak

## Key facts

- **NCT ID:** NCT05210179
- **Lead sponsor:** Health Institutes of Turkey
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-24
- **Primary completion:** 2023-02-25
- **Final completion:** 2023-05-02
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05210179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05210179, "Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05210179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*